LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Spine/Melatonin Slows Down Bone Breakdown
Spine

Melatonin Slows Down Bone Breakdown

June 2, 2014 2 min read Premium comments

Advertisement

Melatonin Slows Down Bone Breakdown
Source: Wikimedia Commons and Murrur
Secondary

Researchers from Canada and Spain are making headway regarding the slowing down of bone breakdown. Faleh Tamimi, DDS, Ph.D., a professor in McGill’s School of Dentistry, is the leader of a research team that has just discovered that melatonin supplements make bones stronger in elderly rats and therefore, potentially, in elderly humans too.

The researchers suspected that a melatonin supplement would help regulate the circadian rhythms of the elderly rats, thus reducing the activity of osteoclasts and slowing down the process of bone breakdown. They were right on target.

Researchers at the University of Madrid, where the rats were housed, gave 20 male rats (22-month-old—the equivalent of 60-year-old humans) melatonin supplements diluted in water for 10 weeks (the equivalent of 6 years in human years). The femurs taken from the elderly rats which had received the melatonin supplements were then compared with those of a control group (which had not received the supplements) using a series of tests to measure bone density and strength.

The researchers found that there was a significant increase in both bone volume and density among the rats that had received melatonin supplements. As a result, it took much more force to break the bones of rats that had taken the melatonin supplements, a finding that suggests to the researchers that melatonin may prove a useful tool in combatting osteoporosis.

For Dr. Tamimi and his colleagues the next big question is whether melatonin is preventing or actually reversing the process of bone breakdown. Dr. Tamimi stated in the May 26, 2014 news release, “Until there is more research as well as clinical trials to determine how exactly the melatonin is working, we can’t recommend that people with osteoporosis go ahead and simply take melatonin supplements. I am applying for funding to pursue the research and we hope to have answers soon.”

Dr. Tamimi told OTW, “We were surprised with the magnitude of the effect of melatonin on the bone of old rats, and the consistency of the results. We expected to see some effect due to melatonin intake, but we didn’t expect it to be as large as we found out. It seems that melatonin could be playing a very important role in bone health when we grow older.”

Regarding future research, Dr. Tamimi noted, “We would test the drug in genetically modified animals in which melatonin receptors are selectively deleted in specific tissues such as the brain and the bones. This way we will be able to pin point the pathways used by the drug to improve bone health.”

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy